The Medical Sensors Market is undergoing a structural transition as decentralized digital care, continuous biometric monitoring, and edge-level AI analytics redefine global healthcare delivery. According to the latest comprehensive intelligence report by Stellar Market Research, the global medical sensors market was valued at USD 25.10 billion in 2023 and is projected to reach USD 46.80 billion by 2030, expanding at a compound annual growth rate (CAGR) of 9.25% over the forecast period (2024–2030). Key Findings from the Report Sensor Type Dominance: Biosensors held the largest market share, commanding over 34% of global revenue, driven by continuous glucose monitoring (CGM) systems, rapid point-of-care infectious disease assays, and wearable blood-chemistry monitors. Technology Leadership: MEMS (Micro-Electro-Mechanical Systems) technology accounted for the dominant market volume owing to extreme miniaturization, low unit-production cost, high sensitivity, and mass integration in disposable pressure sensors and catheter tips. Fastest-Growing Segment: Wearable Sensors (including bio-patches, smart wristwear, and textile-integrated sensors) represent the fastest-growing form factor, expanding at a CAGR exceeding 11.8% due to soaring adoption in remote patient monitoring (RPM) and clinical trial decentralization. Application Benchmark: Monitoring applications generated the majority of demand, led by continuous blood glucose, pulse oximetry ($SpO_2$), body temperature, and multi-lead electrocardiogram (ECG) tracking. Dominant Region: North America led the global market, accounting for over 38% of total revenue, backed by high healthcare expenditure, rapid FDA clearance for digital health tools, and favorable CMS reimbursement policies for remote physiological monitoring. For further information, click the following link:https://www.stellarmr.com/report/req_sample/medical-sensors-market/2331